COMPOUNDS AND METHODS USEFUL FOR TREATING OR PREVENTING HEMATOLOGICAL CANCERS

The present invention includes methods of treating patients with acute myeloid leukemia across a range of genetic subtypes with DHODH inhibitors, such as 6-fluoro-2-(2'fluoro[1,1'- biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid). La présente invention concerne des méthodes de traiteme...

Full description

Saved in:
Bibliographic Details
Main Authors JANZER, ANDREAS, MEYER, HANNA, STOCKIGT, DETLEF, SCADDEN, DAVID, SYKES, DAVID B, LEWIS, TIMOTHY A
Format Patent
LanguageEnglish
French
Published 17.10.2023
Subjects
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present invention includes methods of treating patients with acute myeloid leukemia across a range of genetic subtypes with DHODH inhibitors, such as 6-fluoro-2-(2'fluoro[1,1'- biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid). La présente invention concerne des méthodes de traitement de patients atteints de leucémie myéloïde aiguë sur une plage de sous-types génétiques avec des inhibiteurs de DHODH, de type acide 6-fluoro-2-(2'fluoro[1,1'-biphényl]-4-yl)-3-méthylquinoléine-4-carboxylique.
Bibliography:Application Number: CA20162996632